Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2015 - 2021)

Anika Therapeutics (ANIK) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q1 2021.

• On a quarterly basis, Change in Acquisitions & Divestments fell 83.32% year-over-year to $2.5 million in Q1 2021; TTM through Dec 2021 was $2.5 million, a 94.44% decrease from a year earlier, with the FY2021 full-year figure at $2.5 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments for Q1 2021 stood at $2.5 million, down from $18.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for ANIK reached as high as $58.8 million in Q4 2019 and fell as low as $2.5 million in Q1 2021.
• Historically, Change in Acquisitions & Divestments has averaged $16.6 million across 5 years, with a median of $11.5 million in 2018.
• Across the five-year window, Change in Acquisitions & Divestments surged 411.06% in 2019 and slumped 83.32% in 2021, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $10.2 million in 2017, then increased by 12.2% to $11.5 million in 2018, then jumped by 411.06% to $58.8 million in 2019, then sank by 69.37% to $18.0 million in 2020, then slumped by 86.11% to $2.5 million in 2021.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $2.5 million in Q1 2021, $18.0 million in Q4 2020, and $7.0 million in Q3 2020.